Healthcare provider profile · identity verified

Uzma Anis, M.D.

Internal Medicine · JOHNSON CITY, NY · NPI 1083710321

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	579	213
Levothyroxine Sodium	Levothyroxine Sodium	515	158
Omeprazole	Omeprazole	513	185
Amlodipine Besylate	Amlodipine Besylate	391	123
Lisinopril	Lisinopril	361	129
Pantoprazole Sodium	Pantoprazole Sodium	332	103
Simvastatin	Simvastatin	307	100
Metoprolol Succinate	Metoprolol Succinate	240	92
Alprazolam	Alprazolam	230	70
Furosemide	Furosemide	228	70
Gabapentin	Gabapentin	218	77
Losartan Potassium	Losartan Potassium	209	64
Escitalopram Oxalate	Escitalopram Oxalate	207	62
Metformin Hcl	Metformin Hcl	199	73
Albuterol Sulfate Hfa	Albuterol Sulfate	176	69
Hydrochlorothiazide	Hydrochlorothiazide	161	55
Zolpidem Tartrate	Zolpidem Tartrate	152	30
Valsartan	Valsartan	132	43
Tamsulosin Hcl	Tamsulosin Hcl	129	47
Celecoxib	Celecoxib	127	49
Metoprolol Tartrate	Metoprolol Tartrate	127	45
Fluticasone Propionate	Fluticasone Propionate	120	60
Ozempic	Semaglutide	118	27
Rosuvastatin Calcium	Rosuvastatin Calcium	114	44
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	110	34
Eliquis	Apixaban	107	35
Trazodone Hcl	Trazodone Hcl	107	31
Meloxicam	Meloxicam	106	54
Sertraline Hcl	Sertraline Hcl	103	35
Allopurinol	Allopurinol	102	33
Famotidine	Famotidine	101	41
Fenofibrate	Fenofibrate Nanocrystallized	96	31
Diclofenac Sodium	Diclofenac Sodium	93	41
Clopidogrel	Clopidogrel Bisulfate	90	34
Lorazepam	Lorazepam	86	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	84	34
Tramadol Hcl	Tramadol Hcl	82	30
Carvedilol	Carvedilol	79	28
Citalopram Hbr	Citalopram Hydrobromide	75	27
Methylprednisolone	Methylprednisolone	75	68
Hydralazine Hcl	Hydralazine Hcl	73	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	71	25
Potassium Chloride	Potassium Chloride	71	32
Tizanidine Hcl	Tizanidine Hcl	71	29
Buspirone Hcl	Buspirone Hcl	69	33
Finasteride	Finasteride	69	18
Trulicity	Dulaglutide	68	11
Duloxetine Hcl	Duloxetine Hcl	67	28
Oxybutynin Chloride Er	Oxybutynin Chloride	64	21
Pravastatin Sodium	Pravastatin Sodium	64	23
Atenolol	Atenolol	63	25
Metformin Hcl Er	Metformin Hcl	63	24
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	63	20
Triamcinolone Acetonide	Triamcinolone Acetonide	60	33
Azithromycin	Azithromycin	59	56
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	59	25
Montelukast Sodium	Montelukast Sodium	59	28
Amoxicillin	Amoxicillin	57	51
Jardiance	Empagliflozin	56	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	55	18
Irbesartan	Irbesartan	52	19
Spironolactone	Spironolactone	51	22
Paroxetine Hcl	Paroxetine Hcl	50	14
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	49	19
Enalapril Maleate	Enalapril Maleate	46	16
Cephalexin	Cephalexin	45	33
Glipizide Er	Glipizide	44	17
Alendronate Sodium	Alendronate Sodium	41	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	41	37
Synthroid	Levothyroxine Sodium	40	15
Clonazepam	Clonazepam	38	12
Fluoxetine Hcl	Fluoxetine Hcl	38	17
Venlafaxine Hcl Er	Venlafaxine Hcl	38	suppressed
Mirtazapine	Mirtazapine	37	15
Nystatin	Nystatin	37	22
Farxiga	Dapagliflozin Propanediol	36	suppressed
Ramipril	Ramipril	36	suppressed
Temazepam	Temazepam	36	suppressed
Bupropion Xl	Bupropion Hcl	34	14
Esomeprazole Magnesium	Esomeprazole Magnesium	34	13
Myrbetriq	Mirabegron	34	14
Pregabalin	Pregabalin	34	11
Warfarin Sodium	Warfarin Sodium	34	12
Amitriptyline Hcl	Amitriptyline Hcl	33	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	33	30
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	33	13
Doxepin Hcl	Doxepin Hcl	33	suppressed
Ezetimibe	Ezetimibe	33	suppressed
Glipizide	Glipizide	33	11
Linzess	Linaclotide	33	11
Quetiapine Fumarate	Quetiapine Fumarate	33	suppressed
Baclofen	Baclofen	32	17
Ibuprofen	Ibuprofen	32	19
Xarelto	Rivaroxaban	30	suppressed
Benazepril Hcl	Benazepril Hcl	29	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	15
Januvia	Sitagliptin Phosphate	28	12
Meclizine Hcl	Meclizine Hcl	28	19
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	28	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	27	suppressed
Levetiracetam	Levetiracetam	27	suppressed
Torsemide	Torsemide	26	suppressed
Glimepiride	Glimepiride	25	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Prednisone	Prednisone	25	22
Diazepam	Diazepam	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	16
Zolpidem Tartrate Er	Zolpidem Tartrate	23	suppressed
Klor-Con M20	Potassium Chloride	22	suppressed
Labetalol Hcl	Labetalol Hcl	22	suppressed
Levofloxacin	Levofloxacin	22	19
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	suppressed
Clobetasol Propionate	Clobetasol Propionate	21	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	21	13
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	21	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Eszopiclone	Eszopiclone	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	19
Ondansetron Hcl	Ondansetron Hcl	21	12
Aripiprazole	Aripiprazole	20	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	20	suppressed
Primidone	Primidone	20	suppressed
Naproxen	Naproxen	19	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	18	suppressed
Divalproex Sodium Er	Divalproex Sodium	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	11
Synjardy	Empagliflozin/Metformin Hcl	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Ammonium Lactate	Ammonium Lactate	17	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	17	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	17	suppressed
Fluconazole	Fluconazole	17	14
Janumet	Sitagliptin Phos/Metformin Hcl	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	16	suppressed
Armour Thyroid	Thyroid,pork	15	suppressed
Ciclopirox	Ciclopirox Olamine	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Raloxifene Hcl	Raloxifene Hcl	15	suppressed
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Cefdinir	Cefdinir	14	11
Doxycycline Hyclate	Doxycycline Hyclate	14	13
Fenofibric Acid	Fenofibric Acid (Choline)	14	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Bumetanide	Bumetanide	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Methenamine Hippurate	Methenamine Hippurate	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Dotti	Estradiol	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Nabumetone	Nabumetone	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Acetic Acid	Acetic Acid	11	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Sucralfate	Sucralfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error